Controlled Substance Regulation: Understanding FDA and DEA Missions, Rules, and Policies February 3, 2012 Filed under: Trends-in-Medicine
FDA Advisory Committee Rejects New Indication for Amgen's Xgeva (denosumab) February 3, 2012 Filed under: Trends-in-Medicine
FDA Issues Draft Guidance on Biosimilar Product Development February 3, 2012 Filed under: Trends-in-Medicine